America Partners With Butler Schein Animal Health to Distribute
World's Leading Animal Stem Cell Technology to U.S. Veterinarians
Global leader in animal stem cell technology is poised for significant
expansion through new partnership with top U.S. companion animal health
Las Vegas, Nevada (PRWEB) February 22, 2012
MediVet-America, the global leader in veterinary stem cell technology
and regenerative medicine, has entered into a distribution partnership
with Butler Schein Animal Health, a division of Henry Schein, the
leading companion animal health distribution company in the U.S., to
sell and distribute stem cell kits and equipment to veterinarians
serving the nation's fast-growing $50 billion pet industry.
The announcement was made today at the Western Veterinary Conference in Las Vegas by Jeremy Delk, CEO of MediVet-America.
The two companies will partner to sell and distribute MediVet-America's
advanced stem cell technology to more than 26,000 veterinary clinics
nationwide. Adult animal stem cell technology uses the body's own
regenerative healing power to help treat dogs, cats, horses and other
animals suffering from painful arthritis, hip dysplasia and tendon,
ligament and cartilage injuries and other ailments.
The Adipose-Derived Stem Cell Procedure Kit and state of the art
equipment, co-developed with Medical Australia, enable veterinarians to
remove a small sample of fat, separate the stem cells, then activate and
inject them into affected areas.
"We are pleased to be teaming up with Butler Schein, the largest
companion animal health distribution company in the nation," said Delk.
"Their strong track record in sales and distribution will further fuel
our rapid growth and bring this breakthrough technology to more leading
veterinary practices across the country."
To introduce the distribution partnership, Delk said MediVet-America has
developed an exclusive program of product and service offers that will
be made available only to Butler Schein customers.
Veterinary practitioners in more than 200 markets throughout 42 states
now perform the drug-free procedure entirely in their own clinics more
quickly, effectively and economically than earlier generation animal
stem cell therapy. MediVet-America's new treatment, developed in
Australia, is available in 26 countries worldwide.
"This exciting partnership will allow even more of our colleagues
unparalleled access to MediVet-America's superior technology, providing
the most affordable and efficacious stem cell therapy in the industry,"
said Mike Hutchinson, D.V.M., the world's leading animal stem cell
practitioner. Dr. Hutchinson, who has spoken around the world about stem
cell therapy, most recently in Tokyo, has performed more than 300
procedures over the last 18 months in his practice near Pittsburgh, PA.
MediVet-America is pleased to be teaming up with Butler Schein,
the largest companion animal health distribution company in the nation.
Their strong track record in sales and distribution will further fuel our
rapid growth in stem cell technology. -Jeremy Delk, CEO, MediVet-America
Partnering with the leading animal health manufacturers in the world,
Butler Schein maintains an order-fill ratio greater than 98 percent, and
is positioned to bring the broadest selection of veterinary products
and strategic business solutions to veterinarians, including:
· - A comprehensive product offering for companion animal,
equine and large animal practices including biologicals, diagnostics,
nutritionals, parasiticides and pharmaceuticals
· - Technology hardware and software solutions
· - Capital equipment, supply products and repair services
· - Practice design and remodeling, client marketing and financial solutions
Stem cells are basic biological cells with the ability to differentiate
into specialized tissue cells and regenerate new cells to replace or
repair damaged tissue. The stem cells used in veterinary medicine are
not embryonic, which have attracted controversy over the years, but are
taken from adipose (fat) tissue of the adult animal.
Americans spent an estimated $50.8 billion in 2011 on their companion
animals, according to the American Pet Products Association, up from
$28.5 billion in 2001. MediVet-America's stem cell treatment costs about
$1,800 for small animals, $2,400 for horses. Stem cells also can be
frozen and banked for future use through MediVet Lab Services.
A research and development company and global leader in veterinary stem
cell technology, MediVet-America provides innovative cell applications
for the therapeutic care of animals. Headquartered in Nicholasville,
Kentucky, MediVet-America develops advanced cellular designed kits and
services for the treatment of arthritis and degenerative joint disease.
The company also offers MediVet Lab Services in multiple locations
around the world that provides technical support for in-house stem cell
vets, as well as regional and national Adipose stem cell processing and
cryo banking services for pets at a young age or for a maintenance
program, autologous conditioned serum processing, and cell counting for
in-house stem cell procedures. http://www.MediVet-America.com
BUTLER SCHEIN ANIMAL HEALTH
Butler Schein Animal Health is the leading U.S. companion animal health
distribution company. Headquartered in Dublin, Ohio, the company
operates through 18 distribution centers and 12 telecenters.
Approximately 900 Butler Schein Animal Health team members, including
300 field sales representatives and 200 telesales and customer support
representatives, serve animal health customers in all 50 states. http://www.ButlerShein.com